Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kushner

Showing results (161-170 of 245) with videos related to

Pageof 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 31, 2016
Local Control With 21-Gy Radiation Therapy for High-Risk NeuroblastomaDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Cancer|April 1, 1991
Extracranial primitive neuroectodermal tumors. The Memorial Sloan-Kettering Cancer Center experienceB H Kushner, S I Hajdu, S C Gulati, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalitiesS D Yeh, S M Larson, L Burch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variantsW L Gerald, M Ladanyi, E de Alava, et al.
Cancer Reports (Hoboken, N.J.)|May 17, 2022
Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse eventsJaume Mora, Godfrey C Chan, Daniel A Morgenstern, et al.
Oral Diseases|March 5, 2004
Analyses of variable panoramic radiographic characteristics of maxillo-mandibular fibrous dysplasia in McCune-Albright syndromeS O Akintoye, L L Otis, J C Atkinson, et al.
International Journal of Cancer|January 10, 2026
Naxitamab with novel scheduling and stepped-up dosing of GM-CSF plus vaccine, but no myeloablative therapy for patients with high-risk neuroblastoma in first complete remissionBrian H Kushner, Charlie White, Audrey Mauguen, et al.
Pediatric Blood & Cancer|January 17, 2009
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
International Journal of Cancer|February 11, 2026
A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remissionBrian H Kushner, Shakeel Modak, Charlie White, et al.
Neurosurgery|November 1, 1986
Models of spinal cord injury: Part 1. Static load techniqueP Black, R S Markowitz, V Cooper, et al.
Pageof 25

Showing results (161-170 of 245) with videos related to

Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|July 31, 2016
Local Control With 21-Gy Radiation Therapy for High-Risk NeuroblastomaDana L Casey, Brian H Kushner, Nai-Kong V Cheung, et al.
Cancer|April 1, 1991
Extracranial primitive neuroectodermal tumors. The Memorial Sloan-Kettering Cancer Center experienceB H Kushner, S I Hajdu, S C Gulati, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1991
Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalitiesS D Yeh, S M Larson, L Burch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variantsW L Gerald, M Ladanyi, E de Alava, et al.
Cancer Reports (Hoboken, N.J.)|May 17, 2022
Outpatient administration of naxitamab in combination with granulocyte-macrophage colony-stimulating factor in patients with refractory and/or relapsed high-risk neuroblastoma: Management of adverse eventsJaume Mora, Godfrey C Chan, Daniel A Morgenstern, et al.
Oral Diseases|March 5, 2004
Analyses of variable panoramic radiographic characteristics of maxillo-mandibular fibrous dysplasia in McCune-Albright syndromeS O Akintoye, L L Otis, J C Atkinson, et al.
International Journal of Cancer|January 10, 2026
Naxitamab with novel scheduling and stepped-up dosing of GM-CSF plus vaccine, but no myeloablative therapy for patients with high-risk neuroblastoma in first complete remissionBrian H Kushner, Charlie White, Audrey Mauguen, et al.
Pediatric Blood & Cancer|January 17, 2009
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
International Journal of Cancer|February 11, 2026
A phase II trial of naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in second or later complete remissionBrian H Kushner, Shakeel Modak, Charlie White, et al.
Neurosurgery|November 1, 1986
Models of spinal cord injury: Part 1. Static load techniqueP Black, R S Markowitz, V Cooper, et al.
Pageof 25